Abstract
In the study, human serum albumin functionalized gold nanoparticles (HSA-AuNPs) were fabricated benefiting from the unique properties of HSA and AuNP to achieve tamoxifen delivery to breast cancer cells for renewing tumor targeting with unconventional nanoparticles. The release pattern of tamoxifen (TMX), the cell viability, oxidative DNA damage, and total antioxidant capacity of HSA-AuNP with and without TMX were assessed on BT-474 and MDA MB-231 breast cancer cell lines. The outcomes indicated that TMX entrapped HSA-AuNP can induce cancer cell death in a dose-dependent aspect and could be proved via further studies as a potential drug delivery agent.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Polymeric Materials and Polymeric Biomaterials
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
